Search Results
Results found for "Howard A Rockman"
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
, is professor and chair of the Department of Computational and Quantitative Medicine (DCQM) at the Beckman she became the director of biomolecular simulations at the Materials and Process Simulation Center, Beckman Vaidehi joined the Beckman Research Institute of the City of Hope in 2006 as a Professor and became chair
- Dr. Caron Tribute Part 2 | Dr. GPCR Ecosystem
Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Dr. Caron Tribute Part 1 | Dr. GPCR Ecosystem
Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Dr. Stephane Angers | Dr. GPCR Ecosystem
From 2002-2006 he was a Howard Hughes Post-Doctoral Fellow at the University of Washington in Seattle
- Dr. Caron Tribute Part 3 | Dr. GPCR Ecosystem
Caron was an investigator of the Howard Hughes Medical Institute from 1992 to 2004, a member of the American
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Maudsley was awarded a Howard Hughes Medical Institute Fellowship to train with Professor Robert Lefkowitz
- Dr. Thomas P. Sakmar | Dr. GPCR Ecosystem
After moving to Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced
- Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem
Recognized with the Beckman Young Investigator Award, the Klingenstein-Simons Fellowship in Neuroscience
- 14-Day Trial — Dr. GPCR University | Full Access for $49 | Dr. GPCR Ecosystem
. $49 — credited toward your first year if you stay. 🎓 Dr. your first year Start Your 14 Days Your $49 becomes a credit toward the $499/year membership. You'll receive a $49 coupon toward the $499/year membership. And if you stay, it comes back as a credit toward your first year. Start Your 14 Days $49 credited toward $499/year membership · Net cost $450 if you stay
- Robert J. Lefkowitz: Beta-Adrenergic Receptors, the GPCR Family, and Fifty Years of Discovery | Dr. GPCR Ecosystem
He began his career in the late 1960s and has been an Investigator of the Howard Hughes Medical Institute
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
tone as they dive into Ian’s unique academic journey—from early interests in medicine to his pivot toward
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
The Shift Toward Technology-Driven Biology “Today’s students want to multiplex, miniaturize, and engineer Instead of focusing on a single receptor, students now gravitate toward platforms , biosensors , and
- About Dr. GPCR Podcast | Dr. GPCR Ecosystem
I really appreciate the way the podcast educates and mentors, particularly towards junior scientists
- Your GPCR Order Has Arrived! ❇ Feb 10 - 16, 2025 | Dr. GPCR Ecosystem
Highlights of the Week How Ligands Achieve Biased Signaling toward Arrestins Stéphanie Gaillard , Neha potentiates Kir7.1 to promote food consumption Reviews, GPCRs, and more How Ligands Achieve Biased Signaling toward
- Anita Nivedha: Computational Dynamics of Ligand Bias in GPCR Signaling | Dr. GPCR Ecosystem
Understanding how ligand binding leads to specific signaling outcomes—particularly ligand bias toward “By counting the number of communication pathways toward G proteins versus arrestins, we began to see Communication routes toward G proteins differed from those toward arrestins.
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
inserting them at the top of the heavy chain CDR3, the library enters each panning campaign already biased toward Running multiple libraries in parallel moves the effective diversity toward 10¹² — the idea Aaron calls
- Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
the value of pursuing difficult scientific problems, and how curiosity about drug mechanisms led him toward Kim describes a personal inclination toward challenging research areas. “If someone tells me something is difficult, I tend to run toward it rather than away from it.” We're going to have to push him towards coming onto the podcast.
- Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem
For Blanco-Redondo, the pull toward this work is not abstract. comparing research cultures across continents 08:30 - How adhesion GPCRs entered the picture, and the shift toward
- Dr. John Janetzko | Dr. GPCR Ecosystem
There, I’ve been working towards understanding the molecular basis of G protein-coupled receptor desensitization Towards the end of his PhD, John became interested in understanding how proteins operate as large macromolecular
- Yamina Berchiche: Beyond the Lab — From Chemokine Receptors to the Dr. GPCR Ecosystem | Dr. GPCR Ecosystem
Scientific Themes of the Conversation Chemokine receptor redundancy and the shift toward functional selectivity moment 14:00 Rockefeller, CXCR3, and three splice variants that weren't the same 17:00 NIH and the pull toward
- Dr. Michael Feigin | Dr. GPCR Ecosystem
Towards the end, Mike mentioned that he stayed at Cold Spring Harbor even after his mentor left for Toronto Towards the end, Yamina asked about job opportunities in Mike's lab, to which Mike responded that potential
- Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
Even as the field pushes toward iPSC-derived somatic systems, HEK-cell signaling profiles of μ-opioid Today, Graciela and her team’s efforts are directed towards the characterization of the pharmacological
- From Curiosity to Breakthrough: Ajay Yekkirala on GPCR Innovation | Dr. GPCR Ecosystem
What You’ll Learn in This Episode How Ajay’s failed MD/PhD application rerouted his path toward a breakthrough
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
This conversation covers the arc of that career: the personal loss that drew Bouvier toward the sympathetic chemistry teacher who made synthesis feel real 04:44 A father's death at 39 from hypertension and the path toward
- Media Partner Packages | Dr. GPCR Ecosystem
Launch Campaigns Strategic campaigns that actively drive scientist awareness and traffic toward your
- Annette Gilchrist: Native Cell Systems, Biased Agonism, and the Pharmacogenomics Gap | Dr. GPCR Ecosystem
activity at a wild-type FFA2 receptor, suppressible by an inverse agonist that then redirects signaling toward - and that an inverse agonist against that constitutive activity effectively redirects the receptor toward
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
Activation of a receptor can generate multiple signaling pathways, and different ligands can bias signaling toward Different ligands can bias signaling toward different pathways.
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
Towards the end, Claudia offered advice to junior scientists, suggesting that they explore different




























